<DOC>
	<DOCNO>NCT00874302</DOCNO>
	<brief_summary>Subjects symptomatic uterine fibroid enrol receive daily oral study medication 4 month . This follow 6 month off-drug interval return significant symptomatology . If experience symptom certain severity , subject enter second 4 month treatment cycle follow-up period .</brief_summary>
	<brief_title>Safety Efficacy 25 50 mg Doses Proellex® Treating Recurrence Uterine Fibroid Symptoms</brief_title>
	<detailed_description>Subjects document symptomatic uterine fibroid enrol study . Following screening , subject receive daily oral study medication assess monthly 4 month treatment cycle . This first cycle follow off-drug interval return significant symptomatology . Subjects follow six ( 6 ) month post-treatment . If lack symptom qualify second cycle treatment , discharge study . If experience symptom certain severity , subject enter second 4 month treatment cycle follow-up period .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>At least one uterine fibroid must identifiable measurable Transvaginal Ultrasound ( TVU ) Subject must uterine fibroidassociated symptom thescreening visit Subject menstrual cycle last 20 40 day Other inclusion criterion may apply Postmenopausal woman woman likely become postmenopausal study Subject significant organ abnormality disease ( base Investigator 's judgment ) would opinion Investigator exclude subject participate Subject medical condition , opinion Investigator , compatible study procedure would prevent subject start completing study , interfere subject participate study . Subject acute illness within five day study medication administration Subject endometrial thickness ≥ 18 mm screen ultrasound historically Subject abnormal screen endometrial biopsy include presence Endometrial Intraepithelial Neoplasia ( EIN ) Subject abnormal DEXA scan diagnosis indication osteoporosis screening</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Uterine fibroid</keyword>
</DOC>